+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Flow Cytometry Market Size, Share & Industry Trends Analysis Report By Application (Academic & Clinical and Diagnostic), By End User, By Technology (Cell Based and Bead Based), By Component, By Country and Growth Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 91 Pages
  • August 2022
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5659159
The North America Flow Cytometry Market is expected to witness market growth of 7.8% CAGR during the forecast period (2022-2028).

The standard setup for an experiment starts with fluorescently tagged cells suspended in a single cell, however, any material containing particles can be used. After being placed over the flow cytometer, the specimen is absorbed into the device, where sheath fluid, a physiological buffer, surrounds the cells. The original sample suspension is organized into a single-file sequence of cells by the fluidics system, which consists of the tubing, pumps, and valves, as they move throughout the flow cytometer for examination.

The interrogation point is the location where laser light interacts with the cells. The phrase laser intercept may also be used to describe it. This is where the event occurs. When a single cell is illuminated by a laser beam, some of the light will hit the internal physical components of the cell and disperse. This light scatter may be quantified and associated with internal cell architecture and relative cell size.

The development of technology and its widespread implementation in a variety of research and diagnostics applications are the main drivers of the North American flow cytometry market. Furthermore, it is anticipated that the use of flow cytometric technologies in diagnostic applications will be stimulated by the rising incidence rates of diseases like cancer and HIV. The market's growth rate is also anticipated to be fueled by the strengthening economies of industrialized nations, like the United States and others.

The US market dominated the North America Flow Cytometry Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $2,042.3 million by 2028. The Canada market is poised to grow at a CAGR of 10.3% during (2022 - 2028). Additionally, The Mexico market is expected to witness a CAGR of 9.3% during (2022 - 2028).

Based on Application, the market is segmented into Academic & Clinical and Diagnostic. Based on End User, the market is segmented into Commercial Organizations, Hospitals, Academic Institutions, Medical Schools & Clinical Testing Labs, and Others. Based on Technology, the market is segmented into Cell Based and Bead Based. Based on Component, the market is segmented into Instruments, Reagents & Consumables, Software, and Services. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Becton Dickinson and Company, BioMérieux S.A., Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Miltenyi Biotec B.V. & Co. KG, Sartorius AG, and Sysmex Corporation.

Scope of the Study

Market Segments Covered in the Report:

By Application
  • Academic & Clinical
  • Diagnostic
By End User
  • Commercial Organizations
  • Hospitals
  • Academic Institutions
  • Medical Schools & Clinical Testing Labs
  • Others
By Technology
  • Cell Based
  • Bead Based
By Component
  • Instruments
  • Reagents & Consumables
  • Software
  • Services
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America

Key Market Players

List of Companies Profiled in the Report:

  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • Becton Dickinson and Company
  • BioMérieux S.A.
  • Bio-Rad Laboratories, Inc.
  • DiaSorin S.p.A.
  • Miltenyi Biotec B.V. & Co. KG
  • Sartorius AG
  • Sysmex Corporation

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Flow Cytometry Market, by Application
1.4.2 North America Flow Cytometry Market, by End User
1.4.3 North America Flow Cytometry Market, by Technology
1.4.4 North America Flow Cytometry Market, by Component
1.4.5 North America Flow Cytometry Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. North America Flow Cytometry Market by Application
4.1 North America Academic & Clinical Market by Country
4.2 North America Diagnostic Market by Country
Chapter 5. North America Flow Cytometry Market by End User
5.1 North America Commercial Organizations Market by Country
5.2 North America Hospitals Market by Country
5.3 North America Academic Institutions Market by Country
5.4 North America Medical Schools & Clinical Testing Labs Market by Country
5.5 North America Other End User Market by Country
Chapter 6. North America Flow Cytometry Market by Technology
6.1 North America Cell Based Market by Country
6.2 North America Bead Based Market by Country
Chapter 7. North America Flow Cytometry Market by Component
7.1 North America Instruments Market by Country
7.2 North America Reagents & Consumables Market by Country
7.3 North America Software Market by Country
7.4 North America Services Market by Country
Chapter 8. North America Flow Cytometry Market by Country
8.1 US Flow Cytometry Market
8.1.1 US Flow Cytometry Market by Application
8.1.2 US Flow Cytometry Market by End User
8.1.3 US Flow Cytometry Market by Technology
8.1.4 US Flow Cytometry Market by Component
8.2 Canada Flow Cytometry Market
8.2.1 Canada Flow Cytometry Market by Application
8.2.2 Canada Flow Cytometry Market by End User
8.2.3 Canada Flow Cytometry Market by Technology
8.2.4 Canada Flow Cytometry Market by Component
8.3 Mexico Flow Cytometry Market
8.3.1 Mexico Flow Cytometry Market by Application
8.3.2 Mexico Flow Cytometry Market by End User
8.3.3 Mexico Flow Cytometry Market by Technology
8.3.4 Mexico Flow Cytometry Market by Component
8.4 Rest of North America Flow Cytometry Market
8.4.1 Rest of North America Flow Cytometry Market by Application
8.4.2 Rest of North America Flow Cytometry Market by End User
8.4.3 Rest of North America Flow Cytometry Market by Technology
8.4.4 Rest of North America Flow Cytometry Market by Component
Chapter 9. Company Profiles
9.1 Becton, Dickinson and Company
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Acquisition and Mergers:
9.1.5.3 Approvals and Trials:
9.2 Thermo Fisher Scientific, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Product Launches and Product Expansions:
9.2.5.2 Acquisition and Mergers:
9.3 Danaher Corporation
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Product Launches and Product Expansions:
9.4 Agilent Technologies, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.4.5.2 Acquisition and Mergers:
9.5 BioMérieux S.A.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.6 Bio-Rad laboratories, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.7 DiaSorin S.p.A.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional Analysis
9.7.4 Research & Development Expenses
9.8 Miltenyi Biotech B.V. & Co. KG
9.8.1 Company Overview
9.9 Sartorius AG
9.9.1 Company Overview
9.10. Sysmex Corporation
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Regional Analysis
9.10.4 Research & Development Expense
9.10.5 Recent strategies and developments:
9.10.5.1 Product Launches and Product Expansions:

Companies Mentioned

  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • Becton Dickinson and Company
  • BioMérieux S.A.
  • Bio-Rad Laboratories, Inc.
  • DiaSorin S.p.A.
  • Miltenyi Biotec B.V. & Co. KG
  • Sartorius AG
  • Sysmex Corporation

Methodology

Loading
LOADING...